Current Perspective on the Potential Benefits of Smart Insulin Pens on Glycemic Control in Patients With Diabetes: Spanish Delphi Consensus
Authors' conclusion
The perception of physicians in their usual practice leads them to recommend the use of ambulatory glucose profile and time in range for glycemic control. Forgetting to administer insulin is a very common problem and the actual occurrence rate does not correspond with clinicians' perceptions. Technological improvements and the use of smart insulin pens can increase treatment adherence, strengthen the doctor-patient relationship, and help improve patients' education and quality of life.
Study context
- Population
- Physicians expert in managing patients with T1D, Spain
- Participants
- 110 physician experts
- Outcome
- Expert consensus on smart insulin pens and glycaemic control in T1D
Recommendations
As reported in the abstract
Consensus obtained
95.74%
Patients with time-in-range (TIR) <70% who were diagnosed based on HbA1c values
Between 31% and 65%
Perceived share of patients needing to remember the basal insulin dose
less than 10%
Perceived share of patients needing to remember the prandial insulin dose
between 10% and 30%
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →